참고문헌
- Bornschein J, Rokkas T, Selgrad M, Malfertheiner P (2011). Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter, 16, 45-52. https://doi.org/10.1111/j.1523-5378.2011.00880.x
- Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents, Vol. IX.
- Dos Santos Silva IS (1999). Cancer Epidemiology: Principles and Methods. Int Agency for Res Cancer, Lyon, France, 70-6.
- Ekstrom AM, Hansson LE, Signorello LB, Lindgren A, Bergstrom R, Nyren O (2000). Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. Br J Cancer, 83, 391-6. https://doi.org/10.1054/bjoc.2000.1205
- Eriksson NK, Karkkainen PA, Farkkila MA, Arkkila PE (2008). Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis, 40, 355-60. https://doi.org/10.1016/j.dld.2007.12.012
- Gonzalez CA, Lopez-Carrillo L (2010). Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol, 45, 6-14. https://doi.org/10.3109/00365520903401959
- Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
- Koh TJ, Wang TC (2002).Tumors of the Stomach. In: Feldman M, Friedman LS, Sleisenger MH. Gastrointestinal and Liver Disease.7th edition. USA. SAUNDERS, 829.
- Liu L, Wang ZW, Ji J, et al (2012). A cohort study and metaanalysis between histopathological classification and prognosis of gastric carcinoma. Anticancer Agents Med Chem, 2012 Aug 24. [Epub ahead of print] PubMed PMID:22934699.
- Moghimi-Dehkordi B, Safaee A, Vahedi M, et al (2012). History of upper gastrointestinal cancers in relatives: a communitybased estimate. Gastroenterol Hepatol Bed Bench, 5, 100-5.
- Nyren O, Adami HO (2002). Stomach cancer in: hans-olov adami, david hunter, dimitrios trichopoulos. textbook of cancer epidemiology. USA: Oxford University Press, 162-87.
- Patel SH, Kooby DA (2011). Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am, 91, 1039-77. https://doi.org/10.1016/j.suc.2011.06.009
- Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Abadi AR (2010). Bayesian analysis of gastric cancer mortality in Iranian population. Gastroenterol Hepatol Bed Bench, 3, 15-18.
- Rostami M, Kadivar M, Aznab M, Abachi M (2012). Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran. Gastroenterol Hepatol Bed Bench, 5, 29-34.
- Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8. https://doi.org/10.1002/ijc.11359
- Sipponen P (2002). Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol, 37, 39-44. https://doi.org/10.1007/BF02990098
- Vieth M, Stolte M (2005). Pathology of early upper GI cancers. Best Pract Res Clin Gastroenterol, 19, 857-69. https://doi.org/10.1016/j.bpg.2005.02.008
- Yeoh KG (2007). How do we improve outcomes for gastric cancer? J Gastroenterol Hepatol, 22, 970-2. https://doi.org/10.1111/j.1440-1746.2007.04956.x
- Zali H, Rezaei-Tavirani M, Azodi M (2011). Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench, 4, 175-85
피인용 문헌
- Diagnostic Value of Fecal Calprotectin as a Screening Biomarker for Gastrointestinal Malignancies vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1667